Biotechnology Stock News
Categories
- All
- Editor's Picks
- Stock Market News
- Q&A with Gurus
- Gurus' Stock Picks
- Insider Transaction
- Earning Reports
- CEO Shareholder Letters
- Press Release
- Earnings Call Transcripts
- Podcast
Industries
- Aerospace & Defense
- Agriculture
- Asset Management
- Banks
- Beverages - Alcoholic
- Beverages - Non-Alcoholic
- Biotechnology
- Building Materials
- Business Services
- Capital Markets
- Chemicals
- Conglomerates
- Construction
- Consumer Packaged Goods
- Credit Services
- Diversified Financial Services
- Drug Manufacturers
- Education
- Farm & Heavy Construction Machinery
- Forest Products
- Furnishings, Fixtures & Appliances
- Hardware
- Healthcare Plans
- Healthcare Providers & Services
- Homebuilding & Construction
- Industrial Distribution
- Industrial Products
- Insurance
- Interactive Media
- Manufacturing - Apparel & Accessories
- Media - Diversified
- Medical Devices & Instruments
- Medical Diagnostics & Research
- Medical Distribution
- Metals & Mining
- Oil & Gas
- Other Energy Sources
- Packaging & Containers
- Personal Services
- Real Estate
- REITs
- Restaurants
- Retail - Cyclical
- Retail - Defensive
- Semiconductors
- Software
- Steel
- Telecommunication Services
- Tobacco Products
- Transportation
- Travel & Leisure
- Utilities - Independent Power Producers
- Utilities - Regulated
- Vehicles & Parts
- Waste Management
GuruFocus Research Biotechnology
Sarepta Therapeutics Inc (SRPT) Q1 2024 Earnings Call Transcript Highlights: Robust Revenue Growth and Strategic Advances
Discover key insights from Sarepta Therapeutics' Q1 2024 earnings, including significant revenue increases and promising developments in drug approvals and market expansions. May 02, 2024
GuruFocus Research Biotechnology
Summit Therapeutics Inc (SMMT) Q1 2024 Earnings Call Transcript Highlights: Strategic Insights and Financial Health
Explore key takeaways from Summit Therapeutics' Q1 2024 earnings, including robust financial positioning and pivotal clinical advancements. May 02, 2024
GuruFocus Research Biotechnology
United Therapeutics Corp (UTHR) Q1 2024 Earnings Call Transcript Highlights: Record Revenue and Strategic Advances
Explore key insights from UTHR's Q1 2024 earnings, featuring a 34% revenue surge and significant strides in product development and shareholder initiatives. May 02, 2024
GuruFocus Research Biotechnology
Bio-Techne Corp (TECH) (Q3 2024) Earnings Call Transcript Highlights: Navigating Market Challenges with Strategic Growth
Despite mixed segment performance and macroeconomic pressures, TECH maintains a robust strategic outlook with key advancements in diagnostics and genomics. May 02, 2024
GuruFocus Research Biotechnology
G1 Therapeutics Inc (GTHX) Q1 2024 Earnings Call Transcript Highlights: Strong Revenue Growth and Strategic Advances Amid Challenges
Explore key financial outcomes, strategic developments, and expert insights from G1 Therapeutics' first quarter of 2024 earnings call. May 02, 2024
GuruFocus Research Biotechnology
TG Therapeutics Inc (TGTX) (Q1 2024) Earnings Call Transcript Highlights: Robust Revenue Growth Amidst Strategic Expansions
Despite a net loss, TG Therapeutics Inc reports significant revenue increases and strategic advancements in Q1 2024, setting a positive trajectory for the year. May 02, 2024